No proprietary blends designed to make a label look impressive while obscuring what is actually doing the work
Missing evidence This development could have significant implications for the peptide supply chain
2 The diagnostic process begins with a thorough history
Lack of documentation of scientific need: Because unclassified pills are routinely prohibitively expensive, insurance groups require proof of why the drug was important compared to an older or previously coded alternative
Sikiric P, et al., Stable Gastric Pentadecapeptide BPC 157, Roberts Stomach Cytoprotection/Adaptive Cytoprotection/ Wang T, Treuter E, O
No representations extend beyond controlled experimental settings, and no claims are made regarding biological outcomes, clinical relevance, or applicability outside structured investigational use